Protease activated receptors: theme and variations

Oncogene
P J O'BrienL F Brass

Abstract

The four PAR family members are G protein coupled receptors that are normally activated by proteolytic exposure of an occult tethered ligand. Three of the family members are thrombin receptors. The fourth (PAR2) is not activated by thrombin, but can be activated by other proteases, including trypsin, tryptase and Factor Xa. This review focuses on recent information about the manner in which signaling through these receptors is initiated and terminated, including evidence for inter- as well as intramolecular modes of activation, and continuing efforts to identify additional, biologically-relevant proteases that can activate PAR family members.

References

Apr 1, 1979·The Journal of Clinical Investigation·S Rittenhouse-Simmons
Jun 1, 1976·Thrombosis Research·W WasiewskiJ W Fenton
Nov 2, 1976·Biochemistry·B M MartinT C Detwiler
Mar 25, 1975·Biochemistry·B M MartinT C Detwiler
Feb 1, 1992·The Journal of Clinical Investigation·D T HungS R Coughlin
Oct 1, 1992·The Journal of Clinical Investigation·N A NelkenS R Coughlin
Aug 19, 1991·FEBS Letters·U B RasmussenE Van Obberghen-Schilling
Oct 17, 1991·Nature·T K VuS R Coughlin
Oct 5, 1990·Science·R R FrankeK P Hofmann
Oct 1, 1985·Digestive Diseases and Sciences·H A DaviesS R Bloom
Jan 1, 1986·Annals of the New York Academy of Sciences·M A Shuman
Apr 1, 1988·The Biochemical Journal·M A SelakJ B Smith
Jan 16, 1973·Biochemistry·T C Detwiler, R D Feinman
Feb 1, 1994·Journal of Vascular Surgery·C A LaRosaA D Michelson
Mar 3, 1995·The Journal of Biological Chemistry·V Vouret-CraviariE Van Obberghen-Schilling
Apr 7, 1995·The Journal of Biological Chemistry·V Vouret-CraviariE Van Obberghen-Schilling
Apr 28, 1995·The Journal of Biological Chemistry·M J WoolkalisL F Brass
Mar 17, 1995·The Journal of Biological Chemistry·S NystedtJ Sundelin
Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·S NystedtJ Sundelin
Dec 1, 1994·American Journal of Respiratory and Critical Care Medicine·G H Caughey
Dec 9, 1994·Journal of Molecular Biology·J Doorbar, G Winter
Aug 16, 1994·Proceedings of the National Academy of Sciences of the United States of America·H S SuidanJ Tschopp
Jan 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·L TotaniR Lorenzet
Apr 1, 1993·The Journal of Clinical Investigation·W F BahouM S Goligorsky
Jan 15, 1996·The Biochemical Journal·R J GrandP W Grabham
Jul 12, 1996·The Journal of Biological Chemistry·B D BlackhartR M Scarborough
Sep 6, 1996·The Journal of Biological Chemistry·S K BöhmN W Bunnett

❮ Previous
Next ❯

Citations

Sep 19, 2003·Medical Microbiology and Immunology·Martin ScholzJindrich Cinatl
Jan 12, 2013·Journal of Cardiovascular Translational Research·Giovanni Cimmino, Paolo Golino
Mar 25, 2009·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Vladislava O MelnikovaMenashe Bar-Eli
Feb 1, 2003·Archives of Biochemistry and Biophysics·David B ClearyMuriel C Maurer
Jun 27, 2003·Microvascular Research·Barden ChanVikas P Sukhatme
Sep 24, 2002·Pharmacology & Therapeutics·Rommel S LanPeter J Henry
Jan 30, 2002·Bioorganic & Medicinal Chemistry Letters·Philippe G NantermetHarold G Selnick
Jun 19, 2002·Trends in Cardiovascular Medicine·Matthias Riewald, Wolfram Ruf
Jan 5, 2002·Current Opinion in Pharmacology·F Schmidlin, N W Bunnett
Mar 6, 2002·British Journal of Pharmacology·Ada W Y ChungMarek W Radomski
Mar 10, 2007·Physical Chemistry Chemical Physics : PCCP·Enrico Di CeraLaura C Garvey
May 23, 2009·Cardiovascular Research·Anke C RosenkranzKarsten Schrör
Dec 2, 2009·European Heart Journal·Dominick J AngiolilloShinya Goto
Apr 12, 2003·Critical Care Medicine·Wolfram Ruf, Matthias Riewald
Apr 17, 2009·Pigment Cell & Melanoma Research·Vladislava O Melnikova, Menashe Bar-Eli
Mar 29, 2008·Annual Review of Immunology·Blayne A SayedMelissa A Brown
Nov 8, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Dauren BiyashevClaudie Hecquet
Dec 1, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·L Vijaya Mohan Rao, Usha R Pendurthi
Sep 24, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Leila M SevignyAthan Kuliopulos
Jan 5, 2008·Circulation Research·Gourab BhattacharjeeThomas S Edgington
Dec 9, 2008·American Journal of Respiratory and Critical Care Medicine·Paul F MercerRachel C Chambers
Mar 10, 2004·International Journal of Hematology·Esteban C GabazzaKoji Suzuki
Jun 24, 2008·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Offer ErezChong Jai Kim
Jun 29, 2006·Scandinavian Journal of Gastroenterology·Yutaka IsozakiToshikazu Yoshikawa
Jan 26, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Ayumi SakamotoYasushi Kuraishi
Jul 5, 2006·Journal of Receptor and Signal Transduction Research·Rickard Nordström, Helena Andersson
Mar 13, 2014·Journal of Cellular Physiology·Soledad LangeGareth I Owen
Sep 13, 2003·Chest·Lawrence F Brass
Mar 11, 2008·Molecular Aspects of Medicine·Enrico Di Cera
Oct 27, 2015·SAR and QSAR in Environmental Research·A N HidayatI Yalcin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.